Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03573518 · ClinicalTrials.gov registry record · Phase 2
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
A Phase 2 study, sponsored by Botanix Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 368
- Enrollment target
NCT03573518: Completed Phase 2 study, sponsored by Botanix Pharmaceuticals.
NCT03573518 is a Phase 2 study that has completed, run by Botanix Pharmaceuticals. The registered enrollment target is 368 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (177% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03573518, a Phase 2 study, has completed, sponsored by Botanix Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 368 participants
- Enrollment target
Study Summary
The objective of this study is to assess safety and efficacy of various doses of BTX 1503 liquid formulation in subjects with moderate to severe acne vulgaris of the face.
Primary Outcome
Summary of Treatment-Emergent Adverse Events by MedDra Preferred Term that Occurred with a Frequency \> 2% in any Treatment Group (Safety Population)
Interventions
- DRUG Vehicle
- DRUG BTX 1503
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2018-06-26 |
| Est. Completion | 2019-09-05 |
| Phase | Phase 2 |
What the finished NCT03573518 record still lists
NCT03573518 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (177% higher).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT03573518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03573518 about?
NCT03573518 is a clinical study titled "Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris". The objective of this study is to assess safety and efficacy of various doses of BTX 1503 liquid formulation in subjects with moderate to severe acne vulgaris of the face.
What is the current status of trial NCT03573518?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 368 participants. The study started on 2018-06-26. Estimated completion is 2019-09-05.
What interventions are being tested in trial NCT03573518?
The interventions under investigation include: Vehicle (DRUG), BTX 1503 (DRUG).
Who is sponsoring clinical trial NCT03573518?
This trial is sponsored by Botanix Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03573518's enrollment target sits among peer trials
368 121st of 2000 higher than 1,880 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI